SCHEMBL13624439

SCHEMBL13624439

CS(=O)(=O)c1cc2ccc(Cl)cc2s1

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.45
F10 P00742 10/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791131 0.84 CA2 (0.46) CA2F10
SCHEMBL4625640 0.82 CA2 (0.47) CA2F10
SCHEMBL12157405 0.76 CA2 (0.67) CA2
SCHEMBL12278575 0.74 CA2 (0.40) CA2
SCHEMBL12277798 0.74 CA2 (0.40) CA2
SCHEMBL27526728 0.73 CA2 (0.38) CA2F10
SCHEMBL7012928 0.72 CA2 (0.43) CA2F10
SCHEMBL6726277 0.71 USP2 (0.56) F10
SCHEMBL6730061 0.71 F10 (0.54) F10
SCHEMBL144486 0.71 ALDH1A1 (0.38) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed